Lawmakers, advocates press for diversity in clinical trials
Despite some steps Congress took last year to improve diversity among trial subjects, lawmakers and advocates are pushing for more, including at NIH.
A clinical-research coordinator at Oregon Health and Science University's Knight Cancer Institute in Portland, Ore., draws blood from a clinical-study participant in March 2022. (AP Photo/Gillian Flaccus)
Welcome to National Journal!
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.